The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry

被引:63
作者
Freeman, James V. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha P. [2 ]
Heidenreich, Paul A. [3 ]
Hlatky, Mark A. [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
defibrillation; epidemiology; morbidity; mortality; PERCUTANEOUS CORONARY INTERVENTIONS; UNITED-STATES; PACEMAKER-IMPLANTATION; PRIMARY ANGIOPLASTY; SURGEON VOLUME; OUTCOMES; MORTALITY; OPERATOR; PHYSICIANS;
D O I
10.1016/j.jacc.2010.07.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to examine the relationship between hospital implantable cardioverter-defibrillator (ICD) implantation volume and procedural complications in a contemporary, representative population. Background Hospitals that perform higher volumes of procedures generally have better clinical outcomes. Methods We examined initial ICD implantations between January 2006 and December 2008 at hospitals participating in the NCDR (National Cardiovascular Data Registry) ICD Registry and evaluated the relationship between hospital annual implant volume and in-hospital adverse outcomes. Results The rate of adverse events declined progressively with increasing procedure volume (p trend < 0.0001). This relationship remained significant (p trend < 0.0001) after adjustment for patient clinical characteristics, operator characteristics, and hospital characteristics. The volume-outcome relationship was evident for all ICD subtypes, including single-chamber (p trend = 0.004), dual-chamber (p trend < 0.0001), and biventricular ICDs (p trend = 0.02). Conclusions Patients who have an ICD implanted at a high-volume hospital are less likely to have an adverse event associated with the procedure than patients who have an ICD implanted at a low-volume hospital. (J Am Coll Cardiol 2010;56:1133-9) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 50 条
  • [31] Is it Time for a New Approach to Implantable Cardioverter-Defibrillator Replacement?
    Estes, N. A. Mark, III
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) : 2395 - 2397
  • [32] Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator
    Daubert, J. Claude
    Leclercq, Christophe
    Mabo, Philippe
    [J]. EUROPACE, 2009, 11 : 87 - 92
  • [33] Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy
    Peterson, Pamela N.
    Daugherty, Stacie L.
    Wang, Yongfei
    Vidaillet, Humberto J.
    Heidenreich, Paul A.
    Curtis, Jeptha P.
    Masoudi, Frederick A.
    [J]. CIRCULATION, 2009, 119 (08) : 1078 - U30
  • [34] IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PATCH EROSION PRESENTING AS HEMOPTYSIS
    VERHEYDEN, CN
    PRICE, L
    LYNCH, DJ
    KNIGHT, WL
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1994, 5 (11) : 961 - 963
  • [35] The extravascular implantable cardioverter-defibrillator: The pivotal study plan
    Crozier, Ian
    O'Donnell, David
    Boersma, Lucas
    Murgatroyd, Francis
    Manlucu, Jaimie
    Knight, Bradley P.
    Birgersdotter-Green, Ulrika Maria
    Leclercq, Christophe
    Thompson, Amy
    Sawchuk, Robert
    Willey, Sarah
    Wiggenhorn, Christopher
    Friedman, Paul
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (09) : 2371 - 2378
  • [36] Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies
    Hajduk, Alexandra M.
    Gurwitz, Jerry H.
    Tabada, Grace
    Masoudi, Frederick A.
    Magid, David J.
    Greenlee, Robert T.
    Sung, Sue Hee
    Cassidy-Bushrow, Andrea E.
    Liu, Taylor, I
    Reynolds, Kristi
    Smith, David H.
    Fiocchi, Frances
    Goldberg, Robert
    Gill, Thomas M.
    Gupta, Nigel
    Peterson, Pamela N.
    Schuger, Claudio
    Vidaillet, Humberto
    Hammill, Stephen C.
    Allore, Heather
    Go, Alan S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (07) : 1370 - 1378
  • [37] Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database
    MacFadden, Derek R.
    Crystal, Eugene
    Krahn, Andrew D.
    Mangat, Iqwal
    Healey, Jeffrey S.
    Dorian, Paul
    Birnie, David
    Simpson, Christopher S.
    Khaykin, Yaariv
    Pinter, Arnold
    Nanthakumar, Kumaraswamy
    Calzavara, Andrew J.
    Austin, Peter C.
    Tu, Jack V.
    Lee, Douglas S.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (03) : 195 - +
  • [38] Relation between emotional distress and heart rate variability in patients with an implantable cardioverter-defibrillator
    Hoogwegt, Madelein T.
    Pedersen, Susanne S.
    Theuns, Dominic A. M. J.
    Kupper, Nina
    [J]. PSYCHOPHYSIOLOGY, 2014, 51 (02) : 187 - 196
  • [39] Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: Insights from the National Cardiovascular Data Registry
    Hsu, Jonathan C.
    Varosy, Paul D.
    Parzynski, Craig S.
    Chaudhry, Sarwat I.
    Dewland, Thomas A.
    Curtis, Jeptha P.
    Marcus, Gregory M.
    [J]. AMERICAN HEART JOURNAL, 2015, 169 (01) : 45 - +
  • [40] Patient characteristics and in-hospital complications of subcutaneous implantable cardioverter-defibrillator for Brugada syndrome in Japan
    Kawamura, Iwanari
    Nakajima, Mikio
    Kitamura, Takeshi
    Kaszynski, Richard H.
    Hojo, Rintaro
    Ohbe, Hiroyuki
    Sasabuchi, Yusuke
    Matsui, Hiroki
    Fushimi, Kiyohide
    Fukamizu, Seiji
    Yasunaga, Hideo
    [J]. JOURNAL OF ARRHYTHMIA, 2019, 35 (06) : 842 - 847